Literature DB >> 6716097

The effect of morphine on 5-hydroxytryptamine and catecholamine neurons in the rat brain. Histofluorescence studies.

M Smiałowska, A Bal.   

Abstract

The effect of acute morphine injection (4 or 40 mg/kg, i.p.) on serotonergic (5-HT) and catecholaminergic (CA) neurons in several areas of the rat brain was studied using the Falck-Hillarp histofluorescence method. Changes in fluorescence intensity (i.e. the changes in amine content) were only found in a few discrete regions. Biphasic changes occurred; an initial decrease (after 40 min) was followed by an increase (after 90 min) in amine content of 5-HT nerve cell bodies and CA terminals in the dorsal raphe nucleus and in the region of group B3. Increases were also observed after 90 min in 5-HT nerve cell bodies in the median raphe nucleus and terminals in the nucleus linearis caudalis, and in CA nerve cell bodies in the pars compacta of the substantia nigra and the ventral tagmental area. No significant changes in fluorescence were observed after two weeks chronic morphine treatment. The changes in fluorescence after acute morphine treatment occurred in structures involved in analgesic function. The time-course of these changes suggests that morphine increases both the release and synthesis of 5-HT and CA in these structures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6716097     DOI: 10.1007/bf01249876

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  38 in total

1.  Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal.

Authors:  L M GUNNE
Journal:  Nature       Date:  1959-12-19       Impact factor: 49.962

2.  Response of nigral dopamine neurons to actue and prolonged morphine treatment: effect of exposure to cold, physostigmine and nicotine.

Authors:  R Lienhart; W Lichtensteiger; H Langemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Effect of morphine on the catecholamine content of midbrain nerve cell groups in rat and mouse.

Authors:  U Heinrich; W Lichtensteiger; H Langemann
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

4.  Central monoamines and antinociceptive drug action.

Authors:  B D Görlitz; H H Frey
Journal:  Eur J Pharmacol       Date:  1972-11       Impact factor: 4.432

5.  Relationship between the accumulation of noradrenaline and the development of fluorescence above a constriction in cat splenic nerves.

Authors:  F C Boyle; J S Gillespie
Journal:  J Physiol       Date:  1968-03       Impact factor: 5.182

6.  Proximo-distal transport of [14C]noradrenaline and protein in sympathetic nerves.

Authors:  B G Livett; L B Geffen; L Austin
Journal:  J Neurochem       Date:  1968-09       Impact factor: 5.372

Review 7.  The use of amine fluorescence histochemistry in the study of drugs, especially morphine on the CNS.

Authors:  K Fuxe; L Agnati; P Bolme; B J Everitt; T Hökfelt; G Jonsson; A Ljungdahl; A Löfström
Journal:  Neuropharmacology       Date:  1975-12       Impact factor: 5.250

8.  Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception.

Authors:  J S Mohrland; G F Gebhart
Journal:  Life Sci       Date:  1980 Dec 22-29       Impact factor: 5.037

9.  Effects of narcotic analgesics on serotonin metabolism in brain of rats and mice.

Authors:  A Sawa; T Oka
Journal:  Jpn J Pharmacol       Date:  1976-10

10.  Effects of focal electrical stimulation and morphine microinjection in the periaqueductal gray of the rat mesencephalon on neuronal activity in the medullary reticular formation.

Authors:  J S Mohrland; G F Gebhart
Journal:  Brain Res       Date:  1980-11-10       Impact factor: 3.252

View more
  2 in total

1.  Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide.

Authors:  J L Neisewander; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  Contributions of serotonin in addiction vulnerability.

Authors:  L G Kirby; F D Zeeb; C A Winstanley
Journal:  Neuropharmacology       Date:  2011-04-03       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.